Long Term Extension Study is Designed to Monitor Long-Term Efficacy and Safety of Miravirsen Sodium in Combination With Telaprevir and Ribavirin in Subjects With Chronic Hepatitis C Virus Genotype 1 Infection

Condition:   HCVIntervention:   Sponsor:   Hoffmann-La RocheActive, not recruiting - verified June 2015

Source: ClinicalTrials.gov - May 11, 2015 Category: Research Source Type: clinical trials